NextCure, Inc. - Common Stock (NXTC)

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors.

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

NXTC stock results show that NextCure beat analyst estimates for earnings per share the fourth quarter of 2023.

NXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.

NXTC stock results show that NextCure missed analyst estimates for earnings per share the first quarter of 2024.

The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to 14,822.95. The S&P 500 also rose, gaining, 0.50% to 4,730.68.

  On Tuesday, 89 companies set new 52-week lows.

  On Monday, 79 companies reached new 52-week lows.